Tilray
| Company type | Public |
|---|---|
| Nasdaq: TLRY TSX: TLRY | |
| Industry | Cannabis, Pharmaceutical |
| Founded | 2013 |
| Founder | Brendan Kennedy |
| Headquarters | New York City , United States |
Key people | Irwin D. Simon (CEO) |
| Revenue | US$789 million (2024) |
| US$-222 million (2024) | |
Number of employees | 1,600 (2023) |
| Website | tilray |
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand,Latin America, with growing facilities in Germany, Portugal and the United Kingdom.
In December 2020, the company announced a merger with Aphria, and will operate under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange.
Tilray also owns several breweries and was ranked by the Brewers Association as the 4th largest craft beer company in the US in 2025.